Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Mohammed Aldakkak MD

Mohammed Aldakkak MD profile photo picture

Assistant Professor

Institution: Medical College of Wisconsin
Department: Surgery
Division: Surgery Oncology

Publications (60)

  • AI-Derived Electronic Tumor Marker For Cancer Antigen 19-9 Nonproducers With Pancreatic Ductal Adenocarcinoma. (Thalji SZ, Aldakkak M, Ramamurthi A, Jaraczewski TJ, Belbahri M, SenthilKumar G, Shaik T, Merrill JR, Banerjee A, Taylor BW, Kamgar M, George B, Erickson B, Hall WA, Lytle NK, Seo YD, Christians KK, Clarke CN, Evans DB, Tsai S, Kothari AN) JAMA Surg 2026 May 01;161(5):508-516 PMID: 41848749 PMCID: PMC13000744 SCOPUS ID: 2-s2.0-105034154038 03/18/2026       4 Citations
  • MEK inhibitor-based genomically matched combinatorial targeted therapies in metastatic pancreatic adenocarcinoma with KRAS alterations. (Auckley ED, Yohay S, Ying G, Szabo A, Wittmann J, Grahl J, Aldakkak M, Thalji SZ, McFall T, Kurzrock R, George B, Kamgar M) Oncologist 2026 Feb 17 PMID: 41701177 02/17/2026    
  • Cross-platform comparison of gene expression-based cancer molecular subtyping reveals discrepancies with exome capture methods. (Lee JJ, Aldakkak M, Morrison AB, Thalji SZ, Peng XL, Li Y, Gulley ML, Borazanci EH, Tsai S, Rashid NU, Yeh JJ) NPJ Precis Oncol 2025 Dec 20;10(1):37 PMID: 41422185 PMCID: PMC12819530 SCOPUS ID: 2-s2.0-105028132111 12/21/2025       2 Citations
  • Mutant and Wild-Type RAS Cross-talk and Stoichiometric Deficiencies Are Determinants of Sensitivity to Targeted Therapies in KRASG12R Pancreatic Ductal Adenocarcinoma. (Kamgar M, Hobbs GA, Davidson R, Dorbin D, Herrera J, Langenheim JF, Burge RA, Aldakkak M, Conrardy RD, Szabo A, Thalji SZ, Mayer B, Grahl JJ, Chung BY, Phan A, Thomas JP, Seo YD, Evans DB, Christians KK, Erickson B, Hall WA, George B, Tsai S, Lytle NK, Der CJ, Kurzrock R, McFall T) Cancer Res 2026 Apr 15;86(8):2042-2059 PMID: 41134578 PMCID: PMC13080315 SCOPUS ID: 2-s2.0-105031984871 10/24/2025       1 Citation
  • Exosomal ALPPL2 and THBS2 as biomarkers for early detection and disease monitoring of pancreatic ductal adenocarcinoma. (Halder K, Borazanci EH, Jameson GS, Lin W, Vrana A, Cridebring D, Tsai S, Aldakkak M, Evans DB, Hayashi M, Tanaka H, Kanda M, Goel A, Von Hoff DD, Han H) Br J Cancer 2025 Nov;133(9):1335-1343 PMID: 40897818 PMCID: PMC12572646 SCOPUS ID: 2-s2.0-105015071784 09/03/2025       6 Citations
  • The impact of socioeconomic factors on pancreatic cancer care utilization. (Khani M, Assadi Shalmani M, Taleban A, Tsai S, Nataliansyah M, Aldakkak M, Luo J) PLoS One 2025;20(5):e0320518 PMID: 40333789 PMCID: PMC12057948 SCOPUS ID: 2-s2.0-105004759192 05/07/2025       2 Citations
  • Adjuvant breast radiation therapy practice patterns in the United States from 2012-2017. (Gellings JA, Cortina CS, Kijak J, Bradley J, Aldakkak M, Bergom C, Kong AL) Surg Oncol Insight 2024 Dec;1(4) PMID: 39555478 PMCID: PMC11566854 SCOPUS ID: 2-s2.0-105011035743 11/18/2024       1 Citation
  • Patterns of Locoregional Pancreatic Cancer Recurrence After Total Neoadjuvant Therapy and Implications on Optimal Neoadjuvant Radiation Treatment Volumes. (Beltran Ponce SE, Small CJ, Ahmad T, Patel K, Tsai S, Kamgar M, George B, Kharofa JR, Saeed H, Dua KS, Clarke CN, Aldakkak M, Evans DB, Christians K, Paulson ES, Erickson B, Hall WA) Pract Radiat Oncol 2025;15(1):e47-e56 PMID: 39182645 SCOPUS ID: 2-s2.0-85210733936 08/26/2024       1 Citation
  • The Use of Sentinel Lymph Node Biopsy in Patients Undergoing Mastectomy for DCIS. (Johnson MK, Cortina CS, Aldakkak M, Huang CC, Kong AL) Clin Breast Cancer 2024 Oct;24(7):611-619 PMID: 39127597 PMCID: PMC11402566 SCOPUS ID: 2-s2.0-85200951572 08/11/2024       6 Citations
  • Median arcuate ligament release at the time of pancreaticoduodenectomy or total pancreatectomy. (Ward EP, Vincent-Sheldon S, Tolat P, Kulkarni N, Aldakkak M, Budithi R, Clarke CN, Tsai S, Evans DB, Christians KK) Surgery 2024 May;175(5):1386-1393 PMID: 38413302 SCOPUS ID: 2-s2.0-85186348752 02/28/2024       6 Citations
  • Characterization of an oligometastatic state in patients with metastatic pancreatic adenocarcinoma undergoing systemic chemotherapy. (de Ortiz de Choudens S, Visotcky A, Banerjee A, Aldakkak M, Tsai S, Evans DB, Christians KK, Clarke CN, George B, Shreenivas A, Kamgar M, Chakrabarti S, Dua KS, Khan AH, Madhavan S, Erickson BA, Hall WA) Cancer Med 2024 Jan;13(1):e6582 PMID: 38140796 PMCID: PMC10807686 SCOPUS ID: 2-s2.0-85180644976 12/23/2023    
  • Biliary Adverse Events During Neoadjuvant Therapy for Pancreatic Cancer. (Thalji SZ, Fernando D, Dua KS, Madhavan S, Chisholm P, Smith ZL, Aldakkak M, Christians KK, Clarke CN, George B, Kamgar M, Erickson BA, Hall WA, Evans DB, Tsai S) Ann Surg 2023 Dec 01;278(6):e1224-e1231 PMID: 37078282 SCOPUS ID: 2-s2.0-85176508848 04/20/2023       5 Citations
  • Neoadjuvant chemotherapy for pancreatic cancer: Quality over quantity. (Thalji SZ, Aldakkak M, Christians KK, Clarke CN, George B, Kamgar M, Erickson BA, Hall WA, Chisholm P, Kulkarni N, Doucette S, Evans DB, Tsai S) J Surg Oncol 2023 Jul;128(1):41-50 PMID: 36960919 SCOPUS ID: 2-s2.0-85152449940 03/25/2023       4 Citations
  • CA19-9 Response to First-Line Neoadjuvant FOLFIRINOX and Second-Line Gemcitabine/Nab-Paclitaxel for Patients with Operable Pancreatic Cancer. (Thalji SZ, Kamgar M, George B, Aldakkak M, Christians KK, Clarke CN, Erickson BA, Hall WA, Tolat PP, Smith ZL, Evans DB, Tsai S) Ann Surg Oncol 2023 May;30(5):3013-3021 PMID: 36788189 SCOPUS ID: 2-s2.0-85147934173 02/15/2023       14 Citations
  • Micronuclei in Circulating Tumor Associated Macrophages Predicts Progression in Advanced Colorectal Cancer. (Kasabwala DM, Bergan RC, Gardner KP, Lapidus R, Tsai S, Aldakkak M, Adams DL) Biomedicines 2022 Nov 11;10(11) PMID: 36428466 PMCID: PMC9687174 SCOPUS ID: 2-s2.0-85149480012 11/27/2022       5 Citations
  • Evaluation of Adjuvant Chemotherapy Survival Outcomes Among Patients With Surgically Resected Pancreatic Carcinoma With Node-Negative Disease After Neoadjuvant Therapy. (Hammad AY, Hodges JC, AlMasri S, Paniccia A, Lee KK, Bahary N, Singhi AD, Ellsworth SG, Aldakkak M, Evans DB, Tsai S, Zureikat A) JAMA Surg 2023 Jan 01;158(1):55-62 PMID: 36416848 PMCID: PMC9685551 SCOPUS ID: 2-s2.0-85146193450 11/24/2022       30 Citations
  • Pancreaticogastrostomy as a fistula mitigating strategy for a high-risk pancreatic anastomosis following pancreaticoduodenectomy. (Kazantsev GB, Spitzer AL, Peng PD, Ramirez RM, Chang CK, Tsai S, Aldakkak M, Huyser MR, Dominguez DA) HPB (Oxford) 2023 Jan;25(1):124-135 PMID: 36323594 SCOPUS ID: 2-s2.0-85140984720 11/03/2022       12 Citations
  • CXCR4 expression in tumor associated cells in blood is prognostic for progression and survival in pancreatic cancer. (Gardner KP, Tsai S, Aldakkak M, Gironda S, Adams DL) PLoS One 2022;17(3):e0264763 PMID: 35259193 PMCID: PMC8903256 SCOPUS ID: 2-s2.0-85126077863 03/09/2022       12 Citations
  • Interpreting Sequence Variation in PDAC-Predisposing Genes Using a Multi-Tier Annotation Approach Performed at the Gene, Patient, and Cohort Level. (Zimmermann MT, Mathison AJ, Stodola T, Evans DB, Abrudan JL, Demos W, Tschannen M, Aldakkak M, Geurts J, Lomberk G, Tsai S, Urrutia R) Front Oncol 2021;11:606820 PMID: 33747920 PMCID: PMC7973372 SCOPUS ID: 2-s2.0-85102941394 03/23/2021       7 Citations
  • Circulating stromal cells in resectable pancreatic cancer correlates to pathological stage and predicts for poor clinical outcomes. (Gardner KP, Aldakkak M, Tang CM, Tsai S, Adams DL) NPJ Precis Oncol 2021 Mar 19;5(1):25 PMID: 33742084 PMCID: PMC7979885 SCOPUS ID: 2-s2.0-85116952635 03/21/2021       19 Citations
  • Black Raspberries Suppress Colorectal Cancer by Enhancing Smad4 Expression in Colonic Epithelium and Natural Killer Cells. (Huang YW, Lin CW, Pan P, Shan T, Echeveste CE, Mo YY, Wang HT, Aldakkak M, Tsai S, Oshima K, Yearsley M, Xiao J, Cao H, Sun C, Du M, Bai W, Yu J, Wang LS) Front Immunol 2020;11:570683 PMID: 33424832 PMCID: PMC7793748 SCOPUS ID: 2-s2.0-85098236353 01/12/2021       20 Citations
  • Adjuvant therapy rates and overall survival in patients with localized pancreatic cancer from high Area Deprivation Index neighborhoods. (Mora J, Krepline AN, Aldakkak M, Christians KK, George B, Hall WA, Erickson BA, Kulkarni N, Evans DB, Tsai S) Am J Surg 2021 Jul;222(1):10-17 PMID: 33308823 SCOPUS ID: 2-s2.0-85097458297 12/15/2020       77 Citations
  • Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. (Gao C, Wisniewski L, Liu Y, Staal B, Beddows I, Plenker D, Aldakkak M, Hall J, Barnett D, Gouda MK, Allen P, Drake R, Zureikat A, Huang Y, Evans D, Singhi A, Brand RE, Tuveson DA, Tsai S, Haab BB) Clin Cancer Res 2021 Jan 01;27(1):226-236 PMID: 33093149 PMCID: PMC7785673 SCOPUS ID: 2-s2.0-85100339220 10/24/2020       22 Citations
  • Total Neoadjuvant Therapy for Operable Pancreatic Cancer. (Kim RY, Christians KK, Aldakkak M, Clarke CN, George B, Kamgar M, Khan AH, Kulkarni N, Hall WA, Erickson BA, Evans DB, Tsai S) Ann Surg Oncol 2021 Apr;28(4):2246-2256 PMID: 33000372 SCOPUS ID: 2-s2.0-85091728559 10/02/2020       51 Citations
  • Radiographic patterns of first disease recurrence after neoadjuvant therapy and surgery for patients with resectable and borderline resectable pancreatic cancer. (Barnes CA, Aldakkak M, Christians KK, Clarke CN, Dua K, George B, Ritch PS, Kamgar M, Hall WA, Kulkarni N, Erickson BA, Evans DB, Tsai S) Surgery 2020 Sep;168(3):440-447 PMID: 32641278 SCOPUS ID: 2-s2.0-85087345792 07/10/2020       16 Citations
  • Black raspberries suppress pancreatic cancer through modulation of NKp46+, CD8+, and CD11b+ immune cells. (Pan P, Zhu Z, Oshima K, Aldakkak M, Tsai S, Huang YW, Dong W, Zhang J, Lin CW, Wang Y, Yearsley M, Yu J, Wang LS) Food Front 2020 Mar;1(1):70-82 PMID: 32368735 PMCID: PMC7197210 SCOPUS ID: 2-s2.0-85098260756 05/06/2020       16 Citations
  • Value of Pretreatment 18F-fluorodeoxyglucose Positron Emission Tomography in Patients With Localized Pancreatic Cancer Treated With Neoadjuvant Therapy. (Barnes CA, Aldakkak M, Clarke CN, Christians KK, Bucklan D, Holt M, Tolat P, Ritch PS, George B, Hall WA, Erickson BA, Evans DB, Tsai S) Front Oncol 2020;10:500 PMID: 32363161 PMCID: PMC7180175 SCOPUS ID: 2-s2.0-85084152103 05/05/2020       13 Citations
  • Impact of Neoadjuvant Chemoradiation on Pathologic Response in Patients With Localized Pancreatic Cancer. (Wittmann D, Hall WA, Christians KK, Barnes CA, Jariwalla NR, Aldakkak M, Clarke CN, George B, Ritch PS, Riese M, Khan AH, Kulkarni N, Evans J, Erickson BA, Evans DB, Tsai S) Front Oncol 2020;10:460 PMID: 32351886 PMCID: PMC7175033 SCOPUS ID: 2-s2.0-85084010622 05/01/2020       28 Citations
  • Gross tumor size using the AJCC 8th ed. T staging criteria does not provide prognostic stratification for neoadjuvant treated pancreatic ductal adenocarcinoma. (Rowan DJ, Hartley CP, Aldakkak M, Christians KK, Evans DB, Tsai S, Hagen CE) Ann Diagn Pathol 2020 Jun;46:151485 PMID: 32172219 SCOPUS ID: 2-s2.0-85081260042 03/17/2020       9 Citations
  • Management of Acute Cholecystitis during Neoadjuvant Therapy in Patients with Pancreatic Adenocarcinoma. (Jariwalla NR, Khan AH, Dua K, Christians KK, Clarke CN, Aldakkak M, George B, Tutton S, Rilling W, Erickson B, Evans DB, Tsai S) Ann Surg Oncol 2019 Dec;26(13):4515-4521 PMID: 31641946 SCOPUS ID: 2-s2.0-85074492297 10/24/2019       9 Citations
  • Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgery. (Barnes CA, Chavez MI, Tsai S, Aldakkak M, George B, Ritch PS, Dua K, Clarke CN, Tolat P, Hagen C, Hall WA, Erickson BA, Evans DB, Christians KK) Surgery 2019 Sep;166(3):277-285 PMID: 31272811 SCOPUS ID: 2-s2.0-85068174272 07/06/2019       53 Citations
  • A Serum-Induced Transcriptome and Serum Cytokine Signature Obtained at Diagnosis Correlates with the Development of Early Pancreatic Ductal Adenocarcinoma Metastasis. (Tsai S, McOlash L, Jia S, Zhang J, Simpson P, Kaldunski ML, Aldakkak M, Grewal J, Palen K, Dwinell MB, Johnson BD, Mackinnon A, Hessner MJ, Gershan JA) Cancer Epidemiol Biomarkers Prev 2019 Apr;28(4):680-689 PMID: 30530849 PMCID: PMC6545232 SCOPUS ID: 2-s2.0-85063867816 12/12/2018       2 Citations
  • Distal splenorenal and mesocaval shunting at the time of pancreatectomy. (Chavez MI, Tsai S, Clarke CN, Aldakkak M, Griffin MO, Khan AH, Ritch PS, Erickson BA, Evans DB, Christians KK) Surgery 2019 Feb;165(2):298-306 PMID: 30471779 SCOPUS ID: 2-s2.0-85056892124 11/26/2018       18 Citations
  • Importance of Normalization of CA19-9 Levels Following Neoadjuvant Therapy in Patients With Localized Pancreatic Cancer. (Tsai S, George B, Wittmann D, Ritch PS, Krepline AN, Aldakkak M, Barnes CA, Christians KK, Dua K, Griffin M, Hagen C, Hall WA, Erickson BA, Evans DB) Ann Surg 2020 Apr;271(4):740-747 PMID: 30312198 SCOPUS ID: 2-s2.0-85082099572 10/13/2018       188 Citations
  • Locally advanced pancreas cancer: Staging and goals of therapy. (Chatzizacharias NA, Tsai S, Griffin M, Tolat P, Ritch P, George B, Barnes C, Aldakkak M, Khan AH, Hall W, Erickson B, Evans DB, Christians KK) Surgery 2018 May;163(5):1053-1062 PMID: 29331400 SCOPUS ID: 2-s2.0-85040254084 01/15/2018       56 Citations
  • Characterizing indeterminate liver lesions in patients with localized pancreatic cancer at the time of diagnosis. (Bhalla M, Aldakkak M, Kulkarni NM, O'Connor SD, Griffin MO Jr, Christians KK, Evans DB, Tsai S, Tolat PP) Abdom Radiol (NY) 2018 Feb;43(2):351-363 PMID: 29185014 SCOPUS ID: 2-s2.0-85035138788 12/01/2017       13 Citations
  • Should functional renal scans be obtained prior to upper abdominal IMRT for pancreatic cancer? (Blitzer GC, Hall WA, Tsai S, Aldakkak M, Hellman RS, Evans DB, Christians KK, George B, Ritch PS, Erickson BA) Pract Radiat Oncol 2017;7(6):e449-e455 PMID: 28886941 SCOPUS ID: 2-s2.0-85028763165 09/10/2017    
  • Is Adjuvant Therapy Necessary for All Patients with Localized Pancreatic Cancer Who Have Received Neoadjuvant Therapy? (Barnes CA, Krepline AN, Aldakkak M, Clarke CN, Christians KK, Khan AH, Hunt BC, Ritch PS, George B, Hall WA, Erickson BA, Evans DB, Tsai S) J Gastrointest Surg 2017 Nov;21(11):1793-1803 PMID: 28849366 SCOPUS ID: 2-s2.0-85028529403 08/30/2017       30 Citations
  • Identity and function of a cardiac mitochondrial small conductance Ca2+-activated K+ channel splice variant. (Yang M, Camara AKS, Aldakkak M, Kwok WM, Stowe DF) Biochim Biophys Acta Bioenerg 2017 Jun;1858(6):442-458 PMID: 28342809 PMCID: PMC5749404 SCOPUS ID: 2-s2.0-85017126810 03/28/2017       31 Citations
  • Poor Glycemic Control Is Associated with Failure to Complete Neoadjuvant Therapy and Surgery in Patients with Localized Pancreatic Cancer. (Rajamanickam ES, Christians KK, Aldakkak M, Krepline AN, Ritch PS, George B, Erickson BA, Foley WD, Aburajab M, Evans DB, Tsai S) J Gastrointest Surg 2017 Mar;21(3):496-505 PMID: 27896658 SCOPUS ID: 2-s2.0-84997795492 11/30/2016       11 Citations
  • Stretch-induced increase in cardiac contractility is independent of myocyte Ca2+ while block of stretch channels by streptomycin improves contractility after ischemic stunning. (Rhodes SS, Camara AK, Aldakkak M, Heisner JS, Stowe DF) Physiol Rep 2015 Aug;3(8) PMID: 26290532 PMCID: PMC4562572 SCOPUS ID: 2-s2.0-84987679172 08/21/2015       6 Citations
  • Pre-treatment carbohydrate antigen 19-9 does not predict the response to neoadjuvant therapy in patients with localized pancreatic cancer. (Aldakkak M, Christians KK, Krepline AN, George B, Ritch PS, Erickson BA, Johnston FM, Evans DB, Tsai S) HPB (Oxford) 2015 Oct;17(10):942-52 PMID: 26255895 PMCID: PMC4571763 SCOPUS ID: 2-s2.0-84941878704 08/11/2015       59 Citations
  • Differential effects of buffer pH on Ca(2+)-induced ROS emission with inhibited mitochondrial complexes I and III. (Lindsay DP, Camara AK, Stowe DF, Lubbe R, Aldakkak M) Front Physiol 2015;6:58 PMID: 25805998 PMCID: PMC4354303 SCOPUS ID: 2-s2.0-84926429143 03/26/2015       30 Citations
  • Anaesthetic Postconditioning at the Initiation of CPR Improves Myocardial and Mitochondrial Function in a Pig Model of Prolonged Untreated Ventricular Fibrillation. (Riess ML, Matsuura TR, Bartos JA, Bienengraeber M, Aldakkak M, McKnite SH, Rees JN, Aufderheide TP, Sarraf M, Neumar RW, Yannopoulos D) Resuscitation 2014 Dec;85(12):1745-51 PMID: 25281906 PMCID: PMC4276313 SCOPUS ID: 2-s2.0-84919430815 10/05/2014       24 Citations
  • Safety and Efficacy of Ranolazine for the Treatment of Chronic Angina Pectoris. (Aldakkak M, Stowe DF, Camara AK) Clin Med Insights Ther 2013 Jan 15;2013(5):1-14 PMID: 24574825 PMCID: PMC3932785 SCOPUS ID: 2-s2.0-84872691105 02/28/2014       16 Citations
  • Mitochondrial handling of excess Ca2+ is substrate-dependent with implications for reactive oxygen species generation. (Aldakkak M, Stowe DF, Dash RK, Camara AK) Free Radic Biol Med 2013 Mar;56:193-203 PMID: 23010495 PMCID: PMC3542420 SCOPUS ID: 2-s2.0-84874117448 09/27/2012       29 Citations
  • Protection against cardiac injury by small Ca(2+)-sensitive K(+) channels identified in guinea pig cardiac inner mitochondrial membrane. (Stowe DF, Gadicherla AK, Zhou Y, Aldakkak M, Cheng Q, Kwok WM, Jiang MT, Heisner JS, Yang M, Camara AK) Biochim Biophys Acta 2013 Feb;1828(2):427-42 PMID: 22982251 PMCID: PMC3534888 SCOPUS ID: 2-s2.0-84870201962 09/18/2012       77 Citations
  • Ranolazine reduces Ca2+ overload and oxidative stress and improves mitochondrial integrity to protect against ischemia reperfusion injury in isolated hearts. (Aldakkak M, Camara AK, Heisner JS, Yang M, Stowe DF) Pharmacol Res 2011 Oct;64(4):381-92 PMID: 21741479 PMCID: PMC3233383 SCOPUS ID: 2-s2.0-80052963908 07/12/2011       110 Citations
  • Adding ROS quenchers to cold K+ cardioplegia reduces superoxide emission during 2-hour global cold cardiac ischemia. (Aldakkak M, Stowe DF, Heisner JS, Riess ML, Camara AK) J Cardiovasc Pharmacol Ther 2012 Mar;17(1):93-101 PMID: 21282477 PMCID: PMC3226871 SCOPUS ID: 2-s2.0-84856953884 02/02/2011       9 Citations
  • Mitochondrial matrix K+ flux independent of large-conductance Ca2+-activated K+ channel opening. (Aldakkak M, Stowe DF, Cheng Q, Kwok WM, Camara AK) Am J Physiol Cell Physiol 2010 Mar;298(3):C530-41 PMID: 20053924 PMCID: PMC2838564 SCOPUS ID: 2-s2.0-77749292115 01/08/2010       53 Citations
  • Comparison of cumulative planimetry versus manual dissection to assess experimental infarct size in isolated hearts. (Riess ML, Rhodes SS, Stowe DF, Aldakkak M, Camara AK) J Pharmacol Toxicol Methods 2009;60(3):275-80 PMID: 19732842 PMCID: PMC3786703 SCOPUS ID: 2-s2.0-70449519139 09/08/2009       25 Citations
  • Modulation of mitochondrial bioenergetics in the isolated Guinea pig beating heart by potassium and lidocaine cardioplegia: implications for cardioprotection. (Aldakkak M, Stowe DF, Lesnefsky EJ, Heisner JS, Chen Q, Camara AK) J Cardiovasc Pharmacol 2009 Oct;54(4):298-309 PMID: 19620879 PMCID: PMC2774837 SCOPUS ID: 2-s2.0-74949134558 07/22/2009       29 Citations
  • Enhanced Na+/H+ exchange during ischemia and reperfusion impairs mitochondrial bioenergetics and myocardial function. (Aldakkak M, Stowe DF, Heisner JS, Spence M, Camara AK) J Cardiovasc Pharmacol 2008 Sep;52(3):236-44 PMID: 18806604 PMCID: PMC2659015 SCOPUS ID: 2-s2.0-58149269445 09/23/2008       36 Citations
  • Low-flow perfusion of guinea pig isolated hearts with 26 degrees C air-saturated Lifor solution for 20 hours preserves function and metabolism. (Stowe DF, Camara AK, Heisner JS, Aldakkak M, Harder DR) J Heart Lung Transplant 2008 Sep;27(9):1008-15 PMID: 18765194 PMCID: PMC2720038 SCOPUS ID: 2-s2.0-50249115531 09/04/2008       15 Citations
  • Inhibited mitochondrial respiration by amobarbital during cardiac ischaemia improves redox state and reduces matrix Ca2+ overload and ROS release. (Aldakkak M, Stowe DF, Chen Q, Lesnefsky EJ, Camara AK) Cardiovasc Res 2008 Jan 15;77(2):406-15 PMID: 17900548 SCOPUS ID: 2-s2.0-38849208460 09/29/2007       110 Citations
  • Reverse electron flow-induced ROS production is attenuated by activation of mitochondrial Ca2+-sensitive K+ channels. (Heinen A, Aldakkak M, Stowe DF, Rhodes SS, Riess ML, Varadarajan SG, Camara AK) Am J Physiol Heart Circ Physiol 2007 Sep;293(3):H1400-7 PMID: 17513497 SCOPUS ID: 2-s2.0-34548397692 05/22/2007       96 Citations
  • Ten-hour preservation of guinea pig isolated hearts perfused at low flow with air-saturated Lifor solution at 26{degrees}C: comparison to ViaSpan solution. (Stowe DF, Camara AK, Heisner JS, Aldakkak M, Harder DR) Am J Physiol Heart Circ Physiol 2007 Jul;293(1):H895-901 PMID: 17434975 SCOPUS ID: 2-s2.0-34547129127 04/17/2007       20 Citations
  • ROS scavenging before 27 degrees C ischemia protects hearts and reduces mitochondrial ROS, Ca2+ overload, and changes in redox state. (Camara AK, Aldakkak M, Heisner JS, Rhodes SS, Riess ML, An J, Heinen A, Stowe DF) Am J Physiol Cell Physiol 2007 Jun;292(6):C2021-31 PMID: 17287367 SCOPUS ID: 2-s2.0-34447548815 02/09/2007       41 Citations
  • Mitochondrial Ca2+-induced K+ influx increases respiration and enhances ROS production while maintaining membrane potential. (Heinen A, Camara AK, Aldakkak M, Rhodes SS, Riess ML, Stowe DF) Am J Physiol Cell Physiol 2007 Jan;292(1):C148-56 PMID: 16870831 SCOPUS ID: 2-s2.0-33846300290 07/28/2006       119 Citations
  • Cardiac mitochondrial preconditioning by Big Ca2+-sensitive K+ channel opening requires superoxide radical generation. (Stowe DF, Aldakkak M, Camara AK, Riess ML, Heinen A, Varadarajan SG, Jiang MT) Am J Physiol Heart Circ Physiol 2006 Jan;290(1):H434-40 PMID: 16126810 SCOPUS ID: 2-s2.0-33644799324 08/30/2005       133 Citations
    • Last update: 08/10/2026